Quick Listen: Scrip's Five Must-Know Things
https://scrip.pharmaintelligence.informa.com/SC146762/Quick-Listen-Scrips-Five-MustKnow-Things

Scrip’s Five Must-Know Things – 25 July 2022

Otis Johnson, PhD, Vice President, Product Line Executive; Chief Diversity, Inclusion and Sustainability Officer, at Clario discusses the key changes in the industry that have had the greatest impact, Clario’s first ESG report, and how DE&I initiatives will evolve.

Breaking Barriers Inside and Outside of Clinical Trials

Dr. Ying Huang currently serves as Chief Executive Officer of Legend Biotech. He sits on the Board of Directors of Legend, as well as Quanta Therapeutics.

Dr. Huang brings over 9 years of experience in research and development at major multi-national pharmaceutical companies and 12 years of experience as a biotechnology analyst on Wall Street.

Dr. Huang was a Managing Director and Head of Biotech Equity Research at Bank of America Merrill Lynch where he led a team of analysts covering more than 30 biotechnology companies that encompass a wide range of therapeutic areas. His knowledge and expertise have been recognized by the Institutional Investor survey as a top ranked biotechnology analyst on Wall Street. Dr. Huang previously worked at Wachovia, Credit Suisse, Gleacher and Barclays before joining Bank of America Merrill Lynch. Besides providing investment research to investors, Dr. Huang and his team conducted due diligence for numerous successful initial public offerings (IPOs) and follow-on offerings in the biotechnology sector.

Prior to his Wall Street career, Dr. Huang was a Principal Scientist at Schering-Plough in the Department of Chemical Research focusing on small molecule drug discovery in the therapeutic areas of cardiovascular and central nervous system. He is the co-author of multiple patents and peer reviewed publications. Dr. Huang received his Doctor of Philosophy in Bio-organic Chemistry from Columbia University. He also studied in the Special Class for the Gifted Young at the University of Science and Technology of China and Columbia Business School.

114. Advancing cell therapy and multiple myeloma treatment, Ying Huang, CEO, Legend Biotech

Quick Listen: Scrip's Five Must-Know Things
https://scrip.pharmaintelligence.informa.com/SC146801/Quick-Listen-Scrips-Five-MustKnow-Things

Scrip’s Five Must-Know Things – 1 August 2022

: 世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。
A Japanese-language summary of selected content from Scrip and Pink Sheet, one story at a time.
今回取り上げた記事はこちら
The article for this episode is: MSD’s Asia Pacific Chief On Lagevrio’s Gains In Clinical Utility Amid Paxlovid Luster
（邦題意訳「アジアの医療現場で躍進　コロナ治療薬ラゲブリオの強みと戦略は」）
https://scrip.pharmaintelligence.informa.com/SC146732/MSDs-Asia-Pacific-Chief-On-Lagevrios-Gains-In-Clinical-Utility-Amid-Paxlovid-Luster 
【コンサルティングサービスのご紹介】
ファーマインテリジェンスのコンサルティングチームは、製薬やバイオ技術、医療機器といった分野で活躍する企業のお客様と緊密に連携し、個別の課題をピンポイントで解決します。開発途中の薬剤に関するビジネス機会評価や売上予測、価格予測をはじめ、医療経済評価モデルや臨床試験計画、ベンチマークの策定、協業戦略の策定やポートフォリオの優先順位評価など、幅広いニーズに応え、エビデンスに基づいた意思決定を支援します。今解決したい課題をお持ちの方、ぜひご相談ください。
担当者：今堀 逸太郎（itsutaro.imahori@informa.com）

【3分で解説 世界のファーマ】第4回 コロナ治療薬ラゲブリオ アジアで人気の理由とは

https://scrip.pharmaintelligence.informa.com/SC146845/Quick-Listen-Scrips-Five-MustKnow-Things

Scrip’s Five Must-Know Things – 8 August 2022

MONEY SING (PROD BY. DARK)

Praduman “PJ” Jain, CEO & Founder, Vibrent Health; Principal Investigator, NIH All of Us Research Program, Participant Technology Systems Center; Principal Investigator, NIH RADx Program, discusses his involvement in the NIH All of Us program, digital health research tools, and more.

Meeting People Where They Are

유한양행이 글로벌 제약사로 성장하기 위해 선택한 오픈이노베이션 전략과 R&D 전략에 대해  유한양행의 중앙연구소장이신 오세웅 전무님을 인터뷰한 Scrip기사를 요약한 내용입니다.

https://scrip.pharmaintelligence.informa.com/SC146768/No-Future-Without-New-Drugs-Yuhan-CSO-On-Open-Innovation-Strategy

Korean-language podcast summarising a recent article from Scrip.

‘신약개발 없이 미래는 없다,’ 유한양행의 오픈이노베이션 전략

Buy blue Xanax b707 bar online bllue xanax bar available online without prescription blue xanax b707 free home delivery blue xanax bar online no presceription blue xanax bar pills available xanax with credit card possible
https://actionpills.com/product/blue-xanax-bar/

Buy Blu Xanax b7077bar Online over the counter

Pharma Intelligence from Informa places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Informa is a leader in the field of healthcare industry information.

This medication is prescribed for short-term treatment of generalized anxiety, panic disorders, anxiety associated with depression, and social anxiety disorder .  Alprazolam, sold under the brand name Xanax, . It is most commonly used in short-term management of 
anxiety disorders, specifically panic disorder or generalized anxiety disorder (GAD). 
Other uses include the treatment of chemotherapy-induced nausea, together with other 
treatments. GAD improvement occurs generally within a week

Biotech 2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

New tracks tagged #pharma